ILD during erlotinib and gefitinib treatment in Japanese patients with non-small cell lung cancer.
Stephanie-Jayne
SJ
Jones
Tsveta
T
Milenkova
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D044466:Asian People / Q000706:statistics & numerical data; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000188:drug therapy*; D011379:Prognosis; D011799:Quinazolines / Q000008:administration & dosage
D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib